Dallah Healthcare Company

SASE:4004

Σαουδική Αραβία / Υγεία / Πάροχοι και υπηρεσίες υγειονομικής περίθαλψης

Επισκόπ.

Μερίσματα

Κέρδη

Μοντέλα

Οικονομικές Καταστάσεις

Σύγκριση

Υγεία

Διαγράμματα

Ιστορικό οικ. καταστάσεων 10 ετ.

Τιμή μετοχής

123,60 SAR


Key Metrics	Latest
Total Revenue	3,203 B
Adjusted EBITDA	697,9 M
EBITDA Margin	21,8%
Net Profit Margin	15,6%
Total Assets	6,593 B
Total Debt	2,037 B

10Y Historical Financial Statements

Summary Financials


Summary Financials

	Fiscal Year Ending										Latest
(in millions)	Dec-14	Dec-15	Dec-16	Dec-17	Dec-18	Dec-19	Dec-20	Dec-21	Dec-22	Dec-23	12 Months

Revenue	859	985	1,163	1,212	1,181	1,252	1,318	2,105	2,488	2,943	3,203
% Growth		14.8%	18.0%	4.2%	-2.6%	6.0%	5.3%	59.7%	18.2%	18.3%

Adjusted EBITDA	190	227	290	368	220	231	236	459	514	610	698
% Margin	22.1%	23.0%	24.9%	30.3%	18.6%	18.4%	17.9%	21.8%	20.7%	20.7%	21.8%

Adjusted EBIT	145	170	231	308	146	154	158	361	418	506	586
% Margin	16.9%	17.3%	19.9%	25.4%	12.4%	12.3%	12.0%	17.2%	16.8%	17.2%	18.3%

Adjusted Net Income	147	167	226	303	142	147	109	275	295	386	499
% Margin	17.1%	16.9%	19.4%	25.0%	12.0%	11.7%	8.3%	13.1%	11.8%	13.1%	15.6%

Adjusted Basic EPS	1.63	1.85	2.51	3.37	1.58	1.68	1.27	3.05	3.27	3.96	5.11

Υποστηρικτικοί υπολογισμοί

Income Statement

Balance Sheet

Statement of Cashflows


Income Statement
											Original
SAR	Fiscal Year Ending										Latest
(in millions)	Dec-14	Dec-15	Dec-16	Dec-17	Dec-18	Dec-19	Dec-20	Dec-21	Dec-22	Dec-23	Sep-24
	FY - 9	FY - 8	FY - 7	FY - 6	FY - 5	FY - 4	FY - 3	FY - 2	FY - 1	FY	LTM

Revenue	859	985	1,163	1,212	1,181	1,252	1,318	2,105	2,488	2,943	3,203
% Growth	NA	14.8%	18.0%	4.2%	-2.6%	6.0%	5.3%	59.7%	18.2%	18.3%

Cost of Revenue	(513)	(584)	(644)	(658)	(749)	(811)	(875)	(1,361)	(1,631)	(1,921)	(2,050)
Gross Profit	346	402	519	554	432	441	443	744	857	1,021	1,153
% Revenue	40.3%	40.8%	44.7%	45.7%	36.6%	35.2%	33.6%	35.4%	34.5%	34.7%	36.0%

Research and Development	0	0	0	0	0	0	0	0	0	0	0
Selling and Marketing	(22)	(17)	(25)	(12)	(25)	(24)	(26)	(41)	(45)	(60)	(62)
General and Admin	(179)	(214)	(263)	(234)	(261)	(263)	(281)	(376)	(398)	(489)	(530)
Other Inc / (Exp)	10	8	9	(3)	11	22	25	(3)	(18)	32	56
Total Operating Exp	(191)	(224)	(280)	(249)	(276)	(264)	(281)	(419)	(461)	(517)	(535)

Operating Income	155	178	240	305	157	177	162	325	397	504	618
% Revenue	18.1%	18.1%	20.6%	25.2%	13.3%	14.1%	12.3%	15.4%	15.9%	17.1%	19.3%

Interest Expense	1	(3)	(1)	(0)	(12)	(25)	(13)	(33)	(67)	(104)	(105)
Pre-tax Income	156	175	239	305	145	152	148	292	329	400	512
Earnings of Discontinued Ops.	0	0	0	0	0	0	0	0	0	0	0
Provision for Taxes	(9)	(10)	(14)	(10)	(4)	(5)	(13)	(17)	(34)	(15)	(13)
Net Income to Company	147	165	225	295	142	147	135	275	295	385	499
% Margin	17.1%	16.7%	19.3%	24.3%	12.0%	11.7%	10.2%	13.1%	11.9%	13.1%	15.6%

Minority Interest in Earnings	0	0	0	0	0	0	(3)	(16)	(21)	(25)	(28)
Net Income to Stockholders	147	165	225	295	142	147	132	259	274	360	471

Preferred Dividends	0	0	0	0	0	0	0	0	0	0	0
Other Adj.	0	0	0	0	0	0	0	0	0	0	0

Net Income to Common	147	165	225	295	142	147	132	259	274	360	471
% Margin	17.1%	16.7%	19.3%	24.3%	12.0%	11.7%	10.0%	12.3%	11.0%	12.2%	14.7%

As Reported
Basic EPS (Continuing Ops)	1.63	1.83	2.50	3.28	1.58	1.68	1.53	2.87	3.05	3.70	4.83
Diluted EPS (Continuing Ops)	1.63	1.83	2.50	3.28	1.58	1.68	1.53	2.87	3.05	3.70	4.83

WA Basic Shares Out.	90.00	90.00	90.00	90.00	90.00	87.58	86.08	90.00	90.00	97.34	97.72
WA Diluted Shares Out.	90.00	90.00	90.00	90.00	90.00	87.58	86.08	90.00	90.00	97.34	97.72

EBITDA, EBIT Reconciliation
EBT, Incl. Unusual Items	156	175	239	305	145	152	148	292	329	400	512
Addback: Net Interest Expense	(1)	3	1	0	12	25	13	33	67	104	105
Addback: Other Non Operating Expenses, Total	(10)	(10)	(10)	(9)	(11)	(22)	31	36	23	2	(32)
Addback: Depreciation & Amortization	45	56	59	60	74	76	78	97	96	104	112
Addback: Restructuring Charges	0	0	0	0	0	0	0	0	0	0	0
Addback: Merger / Acquisition Expenses	0	0	0	0	0	0	0	0	0	0	0
Addback: Goodwill Impairment	0	0	5	0	0	0	0	0	0	0	0
Addback: Gain (Loss) On Sale Of Invest.	0	0	(9)	12	0	0	0	0	0	0	0
Addback: Gain (Loss) On Sale Of Assets	0	2	0	(0)	0	0	(35)	(0)	(1)	0	0
Addback: Asset Writedown	0	0	6	0	0	0	0	0	0	0	0
Addback: In Process R&D Expenses	0	0	0	0	0	0	0	0	0	0	0
Addback: Insurance Settlements	0	0	0	0	0	0	0	0	0	0	0
Addback: Legal Settlements	0	0	0	0	0	0	0	0	0	0	0
Addback: Other Unusual Items	0	0	0	0	0	0	0	0	0	0	0
Adjusted EBITDA	190	227	290	368	220	231	236	459	514	610	698
% Margin	22.1%	23.0%	24.9%	30.3%	18.6%	18.4%	17.9%	21.8%	20.7%	20.7%	21.8%

Adjusted EBIT	145	170	231	308	146	154	158	361	418	506	586
% Margin	16.9%	17.3%	19.9%	25.4%	12.4%	12.3%	12.0%	17.2%	16.8%	17.2%	18.3%

Adjusted Net Income Reconciliation
Net Income to Company	147	165	225	295	142	147	135	275	295	385	499
Addback: Unusual Items	0	2	2	11	0	0	(35)	(0)	(1)	0	0
Less: Tax Benefit of Unusual Items (26%)	(0)	(1)	(0)	(3)	(0)	(0)	9	0	0	(0)	(0)
Adjusted Net Income	147	167	226	303	142	147	109	275	295	386	499
% Margin	17.1%	16.9%	19.4%	25.0%	12.0%	11.7%	8.3%	13.1%	11.8%	13.1%	15.6%

Με επιφύλαξη παντός δικαιώματος. Όροι Χρήσης

Σφάλμα φόρτωσης

Dallah Healthcare Company

SASE:4004

Σαουδική Αραβία / Υγεία / Πάροχοι και υπηρεσίες υγειονομικής περίθαλψης

Ιστορικό οικ. καταστάσεων 10 ετ.